Niedersuess-Beke D, Mayrhofer K, Krauter J, Franke J, et al. Enfortumab vedotin plus pembrolizumab in treatment-naive metastatic urothelial carcinoma patients: An Austrian real-world analysis. Int J Cancer 2026;158:1654-1665.
PMID: 41123038